The global Bispecific Antibody Technology Platform market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibody Technology Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibody Technology Platform. This report contains market size and forecasts of Bispecific Antibody Technology Platform in global, including the following market information:
Global Bispecific Antibody Technology Platform Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
IgG-like Bispecific Antibody Platform Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bispecific Antibody Technology Platform include Sanofi, Roche, WuXi Biologics, Merus, Biomunex, Alphamab Oncology, EPIMAB BIOTHERAPEUTICS, INC, Biocytogen and Lonza, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bispecific Antibody Technology Platform companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bispecific Antibody Technology Platform Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Bispecific Antibody Technology Platform Market Segment Percentages, by Type, 2022 (%)
- IgG-like Bispecific Antibody Platform
- Non IgG-like Bispecific Antibody Platform
Global Bispecific Antibody Technology Platform Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Bispecific Antibody Technology Platform Market Segment Percentages, by Application, 2022 (%)
- Tumor Disease
- Hemophilia
- Eye Disease
- Other
Global Bispecific Antibody Technology Platform Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Bispecific Antibody Technology Platform Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Bispecific Antibody Technology Platform revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Bispecific Antibody Technology Platform revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Sanofi
- Roche
- WuXi Biologics
- Merus
- Biomunex
- Alphamab Oncology
- EPIMAB BIOTHERAPEUTICS, INC
- Biocytogen
- Lonza
- Abbott
- Amgen
- Innovent
- Epimab
- Keymed
- Selexis
- SYNIMMUNE
- F-star
- Zymeworks Inc
- Creative Biolabs
- ImmunoPrecise
- CytomX Therapeutics, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bispecific Antibody Technology Platform, market overview.
Chapter 2: Global Bispecific Antibody Technology Platform market size in revenue.
Chapter 3: Detailed analysis of Bispecific Antibody Technology Platform company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bispecific Antibody Technology Platform in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Bispecific Antibody Technology Platform Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bispecific Antibody Technology Platform Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bispecific Antibody Technology Platform Overall Market Size
2.1 Global Bispecific Antibody Technology Platform Market Size: 2022 VS 2030
2.2 Global Bispecific Antibody Technology Platform Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bispecific Antibody Technology Platform Players in Global Market
3.2 Top Global Bispecific Antibody Technology Platform Companies Ranked by Revenue
3.3 Global Bispecific Antibody Technology Platform Revenue by Companies
3.4 Top 3 and Top 5 Bispecific Antibody Technology Platform Companies in Global Market, by Revenue in 2022
3.5 Global Companies Bispecific Antibody Technology Platform Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bispecific Antibody Technology Platform Players in Global Market
3.6.1 List of Global Tier 1 Bispecific Antibody Technology Platform Companies
3.6.2 List of Global Tier 2 and Tier 3 Bispecific Antibody Technology Platform Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Bispecific Antibody Technology Platform Market Size Markets, 2022 & 2030
4.1.2 IgG-like Bispecific Antibody Platform
4.1.3 Non IgG-like Bispecific Antibody Platform
4.2 By Type - Global Bispecific Antibody Technology Platform Revenue & Forecasts
4.2.1 By Type - Global Bispecific Antibody Technology Platform Revenue, 2018-2023
4.2.2 By Type - Global Bispecific Antibody Technology Platform Revenue, 2024-2030
4.2.3 By Type - Global Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bispecific Antibody Technology Platform Market Size, 2022 & 2030
5.1.2 Tumor Disease
5.1.3 Hemophilia
5.1.4 Eye Disease
5.1.5 Other
5.2 By Application - Global Bispecific Antibody Technology Platform Revenue & Forecasts
5.2.1 By Application - Global Bispecific Antibody Technology Platform Revenue, 2018-2023
5.2.2 By Application - Global Bispecific Antibody Technology Platform Revenue, 2024-2030
5.2.3 By Application - Global Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Bispecific Antibody Technology Platform Market Size, 2022 & 2030
6.2 By Region - Global Bispecific Antibody Technology Platform Revenue & Forecasts
6.2.1 By Region - Global Bispecific Antibody Technology Platform Revenue, 2018-2023
6.2.2 By Region - Global Bispecific Antibody Technology Platform Revenue, 2024-2030
6.2.3 By Region - Global Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Bispecific Antibody Technology Platform Revenue, 2018-2030
6.3.2 US Bispecific Antibody Technology Platform Market Size, 2018-2030
6.3.3 Canada Bispecific Antibody Technology Platform Market Size, 2018-2030
6.3.4 Mexico Bispecific Antibody Technology Platform Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Bispecific Antibody Technology Platform Revenue, 2018-2030
6.4.2 Germany Bispecific Antibody Technology Platform Market Size, 2018-2030
6.4.3 France Bispecific Antibody Technology Platform Market Size, 2018-2030
6.4.4 U.K. Bispecific Antibody Technology Platform Market Size, 2018-2030
6.4.5 Italy Bispecific Antibody Technology Platform Market Size, 2018-2030
6.4.6 Russia Bispecific Antibody Technology Platform Market Size, 2018-2030
6.4.7 Nordic Countries Bispecific Antibody Technology Platform Market Size, 2018-2030
6.4.8 Benelux Bispecific Antibody Technology Platform Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Bispecific Antibody Technology Platform Revenue, 2018-2030
6.5.2 China Bispecific Antibody Technology Platform Market Size, 2018-2030
6.5.3 Japan Bispecific Antibody Technology Platform Market Size, 2018-2030
6.5.4 South Korea Bispecific Antibody Technology Platform Market Size, 2018-2030
6.5.5 Southeast Asia Bispecific Antibody Technology Platform Market Size, 2018-2030
6.5.6 India Bispecific Antibody Technology Platform Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Bispecific Antibody Technology Platform Revenue, 2018-2030
6.6.2 Brazil Bispecific Antibody Technology Platform Market Size, 2018-2030
6.6.3 Argentina Bispecific Antibody Technology Platform Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Bispecific Antibody Technology Platform Revenue, 2018-2030
6.7.2 Turkey Bispecific Antibody Technology Platform Market Size, 2018-2030
6.7.3 Israel Bispecific Antibody Technology Platform Market Size, 2018-2030
6.7.4 Saudi Arabia Bispecific Antibody Technology Platform Market Size, 2018-2030
6.7.5 UAE Bispecific Antibody Technology Platform Market Size, 2018-2030
7 Bispecific Antibody Technology Platform Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Bispecific Antibody Technology Platform Major Product Offerings
7.1.4 Sanofi Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Bispecific Antibody Technology Platform Major Product Offerings
7.2.4 Roche Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 WuXi Biologics
7.3.1 WuXi Biologics Company Summary
7.3.2 WuXi Biologics Business Overview
7.3.3 WuXi Biologics Bispecific Antibody Technology Platform Major Product Offerings
7.3.4 WuXi Biologics Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.3.5 WuXi Biologics Key News & Latest Developments
7.4 Merus
7.4.1 Merus Company Summary
7.4.2 Merus Business Overview
7.4.3 Merus Bispecific Antibody Technology Platform Major Product Offerings
7.4.4 Merus Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.4.5 Merus Key News & Latest Developments
7.5 Biomunex
7.5.1 Biomunex Company Summary
7.5.2 Biomunex Business Overview
7.5.3 Biomunex Bispecific Antibody Technology Platform Major Product Offerings
7.5.4 Biomunex Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.5.5 Biomunex Key News & Latest Developments
7.6 Alphamab Oncology
7.6.1 Alphamab Oncology Company Summary
7.6.2 Alphamab Oncology Business Overview
7.6.3 Alphamab Oncology Bispecific Antibody Technology Platform Major Product Offerings
7.6.4 Alphamab Oncology Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.6.5 Alphamab Oncology Key News & Latest Developments
7.7 EPIMAB BIOTHERAPEUTICS, INC
7.7.1 EPIMAB BIOTHERAPEUTICS, INC Company Summary
7.7.2 EPIMAB BIOTHERAPEUTICS, INC Business Overview
7.7.3 EPIMAB BIOTHERAPEUTICS, INC Bispecific Antibody Technology Platform Major Product Offerings
7.7.4 EPIMAB BIOTHERAPEUTICS, INC Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.7.5 EPIMAB BIOTHERAPEUTICS, INC Key News & Latest Developments
7.8 Biocytogen
7.8.1 Biocytogen Company Summary
7.8.2 Biocytogen Business Overview
7.8.3 Biocytogen Bispecific Antibody Technology Platform Major Product Offerings
7.8.4 Biocytogen Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.8.5 Biocytogen Key News & Latest Developments
7.9 Lonza
7.9.1 Lonza Company Summary
7.9.2 Lonza Business Overview
7.9.3 Lonza Bispecific Antibody Technology Platform Major Product Offerings
7.9.4 Lonza Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.9.5 Lonza Key News & Latest Developments
7.10 Abbott
7.10.1 Abbott Company Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Bispecific Antibody Technology Platform Major Product Offerings
7.10.4 Abbott Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.10.5 Abbott Key News & Latest Developments
7.11 Amgen
7.11.1 Amgen Company Summary
7.11.2 Amgen Business Overview
7.11.3 Amgen Bispecific Antibody Technology Platform Major Product Offerings
7.11.4 Amgen Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.11.5 Amgen Key News & Latest Developments
7.12 Innovent
7.12.1 Innovent Company Summary
7.12.2 Innovent Business Overview
7.12.3 Innovent Bispecific Antibody Technology Platform Major Product Offerings
7.12.4 Innovent Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.12.5 Innovent Key News & Latest Developments
7.13 Epimab
7.13.1 Epimab Company Summary
7.13.2 Epimab Business Overview
7.13.3 Epimab Bispecific Antibody Technology Platform Major Product Offerings
7.13.4 Epimab Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.13.5 Epimab Key News & Latest Developments
7.14 Keymed
7.14.1 Keymed Company Summary
7.14.2 Keymed Business Overview
7.14.3 Keymed Bispecific Antibody Technology Platform Major Product Offerings
7.14.4 Keymed Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.14.5 Keymed Key News & Latest Developments
7.15 Selexis
7.15.1 Selexis Company Summary
7.15.2 Selexis Business Overview
7.15.3 Selexis Bispecific Antibody Technology Platform Major Product Offerings
7.15.4 Selexis Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.15.5 Selexis Key News & Latest Developments
7.16 SYNIMMUNE
7.16.1 SYNIMMUNE Company Summary
7.16.2 SYNIMMUNE Business Overview
7.16.3 SYNIMMUNE Bispecific Antibody Technology Platform Major Product Offerings
7.16.4 SYNIMMUNE Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.16.5 SYNIMMUNE Key News & Latest Developments
7.17 F-star
7.17.1 F-star Company Summary
7.17.2 F-star Business Overview
7.17.3 F-star Bispecific Antibody Technology Platform Major Product Offerings
7.17.4 F-star Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.17.5 F-star Key News & Latest Developments
7.18 Zymeworks Inc
7.18.1 Zymeworks Inc Company Summary
7.18.2 Zymeworks Inc Business Overview
7.18.3 Zymeworks Inc Bispecific Antibody Technology Platform Major Product Offerings
7.18.4 Zymeworks Inc Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.18.5 Zymeworks Inc Key News & Latest Developments
7.19 Creative Biolabs
7.19.1 Creative Biolabs Company Summary
7.19.2 Creative Biolabs Business Overview
7.19.3 Creative Biolabs Bispecific Antibody Technology Platform Major Product Offerings
7.19.4 Creative Biolabs Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.19.5 Creative Biolabs Key News & Latest Developments
7.20 ImmunoPrecise
7.20.1 ImmunoPrecise Company Summary
7.20.2 ImmunoPrecise Business Overview
7.20.3 ImmunoPrecise Bispecific Antibody Technology Platform Major Product Offerings
7.20.4 ImmunoPrecise Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.20.5 ImmunoPrecise Key News & Latest Developments
7.21 CytomX Therapeutics, Inc.
7.21.1 CytomX Therapeutics, Inc. Company Summary
7.21.2 CytomX Therapeutics, Inc. Business Overview
7.21.3 CytomX Therapeutics, Inc. Bispecific Antibody Technology Platform Major Product Offerings
7.21.4 CytomX Therapeutics, Inc. Bispecific Antibody Technology Platform Revenue in Global Market (2018-2023)
7.21.5 CytomX Therapeutics, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Bispecific Antibody Technology Platform Market Opportunities & Trends in Global Market
Table 2. Bispecific Antibody Technology Platform Market Drivers in Global Market
Table 3. Bispecific Antibody Technology Platform Market Restraints in Global Market
Table 4. Key Players of Bispecific Antibody Technology Platform in Global Market
Table 5. Top Bispecific Antibody Technology Platform Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Bispecific Antibody Technology Platform Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Bispecific Antibody Technology Platform Revenue Share by Companies, 2018-2023
Table 8. Global Companies Bispecific Antibody Technology Platform Product Type
Table 9. List of Global Tier 1 Bispecific Antibody Technology Platform Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bispecific Antibody Technology Platform Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Bispecific Antibody Technology Platform Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Bispecific Antibody Technology Platform Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Bispecific Antibody Technology Platform Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Bispecific Antibody Technology Platform Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Bispecific Antibody Technology Platform Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Bispecific Antibody Technology Platform Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2024-2030
Table 30. Sanofi Company Summary
Table 31. Sanofi Bispecific Antibody Technology Platform Product Offerings
Table 32. Sanofi Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Bispecific Antibody Technology Platform Product Offerings
Table 36. Roche Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. WuXi Biologics Company Summary
Table 39. WuXi Biologics Bispecific Antibody Technology Platform Product Offerings
Table 40. WuXi Biologics Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 41. WuXi Biologics Key News & Latest Developments
Table 42. Merus Company Summary
Table 43. Merus Bispecific Antibody Technology Platform Product Offerings
Table 44. Merus Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 45. Merus Key News & Latest Developments
Table 46. Biomunex Company Summary
Table 47. Biomunex Bispecific Antibody Technology Platform Product Offerings
Table 48. Biomunex Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 49. Biomunex Key News & Latest Developments
Table 50. Alphamab Oncology Company Summary
Table 51. Alphamab Oncology Bispecific Antibody Technology Platform Product Offerings
Table 52. Alphamab Oncology Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 53. Alphamab Oncology Key News & Latest Developments
Table 54. EPIMAB BIOTHERAPEUTICS, INC Company Summary
Table 55. EPIMAB BIOTHERAPEUTICS, INC Bispecific Antibody Technology Platform Product Offerings
Table 56. EPIMAB BIOTHERAPEUTICS, INC Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 57. EPIMAB BIOTHERAPEUTICS, INC Key News & Latest Developments
Table 58. Biocytogen Company Summary
Table 59. Biocytogen Bispecific Antibody Technology Platform Product Offerings
Table 60. Biocytogen Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 61. Biocytogen Key News & Latest Developments
Table 62. Lonza Company Summary
Table 63. Lonza Bispecific Antibody Technology Platform Product Offerings
Table 64. Lonza Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 65. Lonza Key News & Latest Developments
Table 66. Abbott Company Summary
Table 67. Abbott Bispecific Antibody Technology Platform Product Offerings
Table 68. Abbott Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 69. Abbott Key News & Latest Developments
Table 70. Amgen Company Summary
Table 71. Amgen Bispecific Antibody Technology Platform Product Offerings
Table 72. Amgen Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 73. Amgen Key News & Latest Developments
Table 74. Innovent Company Summary
Table 75. Innovent Bispecific Antibody Technology Platform Product Offerings
Table 76. Innovent Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 77. Innovent Key News & Latest Developments
Table 78. Epimab Company Summary
Table 79. Epimab Bispecific Antibody Technology Platform Product Offerings
Table 80. Epimab Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 81. Epimab Key News & Latest Developments
Table 82. Keymed Company Summary
Table 83. Keymed Bispecific Antibody Technology Platform Product Offerings
Table 84. Keymed Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 85. Keymed Key News & Latest Developments
Table 86. Selexis Company Summary
Table 87. Selexis Bispecific Antibody Technology Platform Product Offerings
Table 88. Selexis Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 89. Selexis Key News & Latest Developments
Table 90. SYNIMMUNE Company Summary
Table 91. SYNIMMUNE Bispecific Antibody Technology Platform Product Offerings
Table 92. SYNIMMUNE Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 93. SYNIMMUNE Key News & Latest Developments
Table 94. F-star Company Summary
Table 95. F-star Bispecific Antibody Technology Platform Product Offerings
Table 96. F-star Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 97. F-star Key News & Latest Developments
Table 98. Zymeworks Inc Company Summary
Table 99. Zymeworks Inc Bispecific Antibody Technology Platform Product Offerings
Table 100. Zymeworks Inc Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 101. Zymeworks Inc Key News & Latest Developments
Table 102. Creative Biolabs Company Summary
Table 103. Creative Biolabs Bispecific Antibody Technology Platform Product Offerings
Table 104. Creative Biolabs Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 105. Creative Biolabs Key News & Latest Developments
Table 106. ImmunoPrecise Company Summary
Table 107. ImmunoPrecise Bispecific Antibody Technology Platform Product Offerings
Table 108. ImmunoPrecise Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 109. ImmunoPrecise Key News & Latest Developments
Table 110. CytomX Therapeutics, Inc. Company Summary
Table 111. CytomX Therapeutics, Inc. Bispecific Antibody Technology Platform Product Offerings
Table 112. CytomX Therapeutics, Inc. Bispecific Antibody Technology Platform Revenue (US$, Mn) & (2018-2023)
Table 113. CytomX Therapeutics, Inc. Key News & Latest Developments
List of Figures
Figure 1. Bispecific Antibody Technology Platform Segment by Type in 2022
Figure 2. Bispecific Antibody Technology Platform Segment by Application in 2022
Figure 3. Global Bispecific Antibody Technology Platform Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bispecific Antibody Technology Platform Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Bispecific Antibody Technology Platform Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bispecific Antibody Technology Platform Revenue in 2022
Figure 8. By Type - Global Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
Figure 9. By Application - Global Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
Figure 10. By Type - Global Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
Figure 12. By Application - Global Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
Figure 14. By Region - Global Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
Figure 15. By Country - North America Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
Figure 16. US Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
Figure 20. Germany Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 21. France Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
Figure 28. China Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 32. India Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
Figure 34. Brazil Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Bispecific Antibody Technology Platform Revenue Market Share, 2018-2030
Figure 37. Turkey Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Bispecific Antibody Technology Platform Revenue, (US$, Mn), 2018-2030
Figure 41. Sanofi Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. WuXi Biologics Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merus Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Biomunex Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Alphamab Oncology Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. EPIMAB BIOTHERAPEUTICS, INC Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Biocytogen Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Lonza Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Abbott Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Amgen Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Innovent Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Epimab Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Keymed Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Selexis Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. SYNIMMUNE Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. F-star Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Zymeworks Inc Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Creative Biolabs Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. ImmunoPrecise Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. CytomX Therapeutics, Inc. Bispecific Antibody Technology Platform Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
